Microbot Medical (MBOT): Why an FDA Pop May Be Capped by Warrant Supply

We believe Microbot is likely to receive FDA clearance and get a short-term boost to its stock price as a result. Trouble is, the company is sitting on a massive block of in-the-money warrants that holders are already exercising aggressively.